Targeting Metabolic and Molecular Drivers to Stop Treatment- And Immune-Resistant Pancreatic Ductal Adenocarcinoma (UCLA Case No. 2025-9AD)

Contact UCLA Technology Development Group to learn more.

Download as PDF

For More Information:

Dan-Oscar Antson

Business Development Officer (BDO)

dan-oscar.antson@tdg.ucla.edu

Inventors:

Richard Pietras

Categories:

Therapeutics > Gastroenterology

Therapeutics > Oncology